Skip to main content
. 2018;19(6):1617–1620. doi: 10.22034/APJCP.2018.19.6.1617

Table 1.

Characteristics of the Total Population

Characteristic All Patients Node - Node + P Value
Age (SD) 48.45 (11.4) 48.15 (11.52) 48.62 (11.34) 0.9
Tumor Size (%) T1 163 (21.1) 97 (35.3) 66 (13.2) <0.001
T2 611 (78.9) 178 (64.7) 433 (86.8)
LVI (%) Negative 375 (55.5) 185 (75.2) 190 (44.2) 0.001
Positive 301 (44.5) 61 (24.8) 240 (55.8)
Tumor Grade (%) 1,2 480 (67) 190 (74) 290 (63.2) 0.004
3 236 (33) 67 (26.1) 169 (36.8)
ER/PR (%) Negative 183 (23.7) 76 (27.6) 107 (21.5) 0.063
Positive 589 (76.3) 199 (72.4) 390 (78.5)
HER 2 (%) Negative 451 (74.3) 172 (80.4) 279 (71) 0.012
Positive 156 (25.7) 42 (19.6) 114 (29)
Pathology (%) IDC 701 (92) 244 (90.7) 457 (92.7) 0.61
ILC 43 (5.6) 18 (6.7) 25 (5.1)
Mixed 18 (2.4) 7 (2.6) 11 (2.2)

ER, estrogen receptor; PR, progesterone receptor; LVI, Lymphovascular invasion; IDC, Invasive ductal carcinoma; ILC, Invasive lobular carcinoma